Scientists probe immune Cells' role in scleroderma blood vessel damage
NCT ID NCT02636127
First seen May 09, 2026 · Last updated May 11, 2026 · Updated 1 time
Summary
This study looked at how certain immune cells (T cells and NK cells) might harm blood vessels in people with systemic sclerosis (scleroderma). Researchers collected blood samples from 30 participants to measure a molecule called Fractalkine and study how these immune cells interact with blood vessel cells. The goal was to better understand the disease process, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCLERODERMA, SYSTEMIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Assistance Publique Hopitaux de Marseille
Marseille, 13354, France
Conditions
Explore the condition pages connected to this study.